REVBW
Revelation Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
−2.99%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-35.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 5, 2026 | ROPER JESS · director | F-InKind | 1,591 | $1.85 |
| Feb 5, 2026 | Chawla Lakhmir S · director | F-InKind | 2,261 | $1.85 |
| Feb 5, 2026 | CARVER JENNIFER · director | F-InKind | 1,661 | $1.87 |
| Feb 5, 2026 | Rolke James · director, officer: Chief Executive Officer | F-InKind | 8,521 | $1.86 |
| Feb 5, 2026 | Zygmont Chester Stanley III · officer: Chief Financial Officer | F-InKind | 13,100 | $1.65 |
| Jan 12, 2026 | Rolke James · director, officer: Chief Executive Officer | A-Award | 532,829 | $0.90 |
| Jan 12, 2026 | Zygmont Chester Stanley III · officer: Chief Financial Officer | A-Award | 78,145 | $0.90 |
| Jan 12, 2026 | CARVER JENNIFER · director | A-Award | 41,981 | $0.90 |
| Jan 12, 2026 | ROPER JESS · director | A-Award | 41,981 | $0.90 |
| Jan 12, 2026 | Chawla Lakhmir S · director | A-Award | 41,981 | $0.90 |
| Oct 31, 2025 | Chawla Lakhmir S · director | A-Award | 15,625 | $1.28 |
| Oct 31, 2025 | Rolke James · director, officer: Chief Executive Officer | A-Award | 390,614 | $1.28 |
| Oct 31, 2025 | CARVER JENNIFER · director | A-Award | 15,625 | $1.28 |
| Oct 31, 2025 | Zygmont Chester Stanley III · officer: Chief Financial Officer | A-Award | 390,614 | $1.28 |
| Oct 31, 2025 | ROPER JESS · director | A-Award | 15,625 | $1.28 |
| Feb 13, 2025 | Chawla Lakhmir S · director | A-Award | 181 | $3.87 |
| Feb 13, 2025 | CARVER JENNIFER · director | A-Award | 181 | $3.87 |
| Feb 13, 2025 | ROPER JESS · director | A-Award | 181 | $3.87 |
| Feb 13, 2025 | Rolke James · director, officer: Chief Executive Officer | A-Award | 30,095 | $3.87 |
| Feb 13, 2025 | Zygmont Chester Stanley III · officer: Chief Financial Officer | A-Award | 15,048 | $3.87 |
| Feb 13, 2025 | TIDMARSH GEORGE F · director | A-Award | 181 | $3.87 |
| Dec 12, 2023 | TIDMARSH GEORGE F · director | Sale | 27,771 | $0.52 |
| Oct 18, 2023 | TIDMARSH GEORGE F · director | Sale | 1,845 | $0.65 |
| Oct 17, 2023 | TIDMARSH GEORGE F · director | Sale | 10,957 | $0.66 |
| Oct 2, 2023 | TIDMARSH GEORGE F · director | Sale | 1,429 | $0.69 |
| Sep 18, 2023 | TIDMARSH GEORGE F · director | Sale | 12,000 | $0.75 |
| Sep 18, 2023 | TIDMARSH GEORGE F · director | Sale | 9,500 | $0.73 |
| Sep 18, 2023 | TIDMARSH GEORGE F · director | Sale | 4,000 | $0.74 |
| Apr 19, 2023 | TIDMARSH GEORGE F · director | Purchase | 25,000 | $1.16 |
| Apr 19, 2023 | TIDMARSH GEORGE F · director | Purchase | 26,500 | $1.16 |
Institutional positioning
13F filings over the trailing two quarters
New 1Increased 3Reduced 2Sold out 10
| Filer | Action | Shares | Filed |
|---|---|---|---|
| LINDEN ADVISORS LP | Unchanged | 338,110 | May 15, 2026 |
| CLEAR STREET GROUP INC. | Increased | 247,534 | May 15, 2026 |
| Pine Valley Investments Ltd Liability Co | Unchanged | 245,429 | Jun 8, 2026 |
| T3 Companies, LLC | Unchanged | 198,090 | May 7, 2026 |
| TORONTO DOMINION BANK | Increased | 99,550 | May 15, 2026 |
| WOLVERINE ASSET MANAGEMENT LLC | Unchanged | 54,752 | May 4, 2026 |
| JANE STREET GROUP, LLC | Unchanged | 50,000 | May 12, 2026 |
| SOLTIS INVESTMENT ADVISORS LLC | Reduced | 47,500 | Apr 27, 2026 |
| CITADEL ADVISORS LLC | Increased | 32,400 | May 15, 2026 |
| CITADEL ADVISORS LLC | Reduced | 18,716 | Sep 2, 2026 |
| UBS GROUP AG | New Position | 532 | May 5, 2026 |
| QUAKER WEALTH MANAGEMENT, LLC | Unchanged | 387 | Apr 10, 2026 |
| TORONTO DOMINION BANK | Sold Out | 0 | May 15, 2026 |
| Pine Valley Investments Ltd Liability Co | Sold Out | 0 | Jun 8, 2026 |
| Clear Street Group Inc. | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 5, 2026